This inventor holds 2 USPTO granted patents and 4 published patent applications, plus 2 CIPO patents. Top assignee: Biomarin Pharmaceutical Inc.. Active years: 2019-2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019-2020
Title: Innovations by Inventor Shripad Bhagwat
Introduction
Shripad Bhagwat is a notable inventor based in Novato, CA (US). He has made significant contributions to the field of biochemistry, particularly in the development of histone deacetylase inhibitors. With a total of 2 patents, Bhagwat's work is paving the way for advancements in therapeutic methods.
Latest Patents
His latest patents focus on histone deacetylase inhibitors. These patents provide compounds and methods for inhibiting histone deacetylase (HDAC) enzymes, specifically HDAC1, HDAC2, and HDAC3. This innovative approach has the potential to impact various medical treatments.
Career Highlights
Shripad Bhagwat is currently associated with BioMarin Pharmaceutical Inc., where he continues to work on groundbreaking research. His expertise in biochemistry and pharmacology has positioned him as a valuable asset in the pharmaceutical industry.
Collaborations
Throughout his career, Bhagwat has collaborated with esteemed colleagues such as Gregory R. Luedtke and Alexander James Bridges. These partnerships have fostered an environment of innovation and creativity in their research endeavors.
Conclusion
In summary, Shripad Bhagwat is a distinguished inventor whose work on histone deacetylase inhibitors is making significant strides in the field of biochemistry. His contributions are essential for the advancement of therapeutic methods in medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile